ABCC1 p.Tyr440Phe

[switch to full view]
Comments [show]
Publications
PMID: 18775981 [PubMed] Grant CE et al: "Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3)."
No. Sentence Comment
13 It is noteworthy that substitution of Tyr440 with Phe, as found in MRP3, reduced LTC4 and GSH-stimulated estrone-3-sulfate transport without affecting transport of other substrates tested.
X
ABCC1 p.Tyr440Phe 18775981:13:38
status: NEW
Login to comment

138 The most dramatic reduction in transport was found for one double mutation located in the G1 region, Y440F/I441L, which reduced LTC4 transport to less than 20% of wild-type levels (Fig. 3B).
X
ABCC1 p.Tyr440Phe 18775981:138:101
status: NEW
Login to comment

142 With the exception of one triple mutation, in which substitution of M443 with L was introduced into the LTC4 transport-deficient Y440F/I441L double mutant, no combination of mutations tested reduced LTC4 transport by more than 60 to 70% (data not shown).
X
ABCC1 p.Tyr440Phe 18775981:142:129
status: NEW
Login to comment

143 The Y440F/I441L/M443L virtually eliminated LTC4 transport (Fig. 3B) but also reduced E217betaG transport by approximately 80% (Fig. 3C).
X
ABCC1 p.Tyr440Phe 18775981:143:4
status: NEW
Login to comment

144 Transport of LTC4, E217betaG, E13SO4, and MTX by Y440F, I441L, and M443L MRP1 Mutant Proteins.
X
ABCC1 p.Tyr440Phe 18775981:144:49
status: NEW
Login to comment

156 The Y440F and M443L mutations each independently decreased initial rates of LTC4 transport by approximately 60 and 50%, respectively, whereas the I441L mutation had little or no effect (Fig. 3B).
X
ABCC1 p.Tyr440Phe 18775981:156:4
status: NEW
Login to comment

157 In contrast, E217betaG transport was decreased approximately 50% by both the I441L and M443L mutations but only 20% by the Y440F mutation (Fig. 3C).
X
ABCC1 p.Tyr440Phe 18775981:157:123
status: NEW
Login to comment

158 All three mutations significantly decreased E13SO4 transport in the presence of 2 mM S-methyl GSH, with the Y440F, I441L, and M443L mutations reducing transport at 1 min by approximately 65, 50, and 90%, respectively (Fig. 3D).
X
ABCC1 p.Tyr440Phe 18775981:158:108
status: NEW
Login to comment

175 Kinetic Parameters of [3 H]LTC4 Transport by Y440F and I441L Single and Double Mutants.
X
ABCC1 p.Tyr440Phe 18775981:175:45
status: NEW
Login to comment

176 We also determined the effects of the Y440F and I441L single and double mutations on the Km and Vmax for LTC4 transport.
X
ABCC1 p.Tyr440Phe 18775981:176:38
status: NEW
Login to comment

177 The Km and Vmax values obtained for wild-type MRP1 were 72 nM and 37 pmol/mg/min, respectively, whereas the Km for the Y440F mutation was 328 nM and the normalized Vmax was 41 pmol/mg/min (Fig. 4, A and B).
X
ABCC1 p.Tyr440Phe 18775981:177:119
status: NEW
Login to comment

193 Mutations Included 23 M443L/Y440F/1441L 24 A481G/V482A/M483V/M485V 25 V479L/A481G/V482A/M483V/M485V 26 A493K/H494Q/S497L/N500S 27 V479L/A481G/V482A/M483V/M485V 28 V479L/A481G/V482A/M483V/N500S 29 A493K/H494Q/S497L/N500S/N506S 30 A493K/H494Q/S497L/N506S/T487M/K488R/T489A/Y490F consequence, it was technically impossible to determine an accurate Km for LTC4.
X
ABCC1 p.Tyr440Phe 18775981:193:28
status: NEW
Login to comment

195 To confirm whether the increase in Km resulting from the Y440F mutation reflected a decreased affinity for substrate, we examined the effect of the mutation on photolabeling of MRP1 with [3 H]LTC4.
X
ABCC1 p.Tyr440Phe 18775981:195:57
status: NEW
Login to comment

201 However, photolabeling of the NH2-terminal fragments of both the Y440F and double Y440F/I441L mutant proteins was similarly, substantially reduced compared with both the wild-type and the I441L mutant.
X
ABCC1 p.Tyr440Phe 18775981:201:65
status: NEW
X
ABCC1 p.Tyr440Phe 18775981:201:82
status: NEW
Login to comment

203 Furthermore, photolabeling of the COOH-terminal fragment of the Y440F and Y440F/I441L mutant proteins was also reduced when compared with wild-type MRP1 or the I441L mutant, despite the fact that this region is identical in all four proteins.
X
ABCC1 p.Tyr440Phe 18775981:203:64
status: NEW
X
ABCC1 p.Tyr440Phe 18775981:203:74
status: NEW
Login to comment

209 All of these mutations had a greater effect on transport than the more conservative Y440F mutation.
X
ABCC1 p.Tyr440Phe 18775981:209:84
status: NEW
Login to comment

213 In addition, unlike the Y440F mutation, which had little effect on E217betaG transport, the Y440W mutation essentially eliminated transport of the conjugated estrogen (Fig. 6B).
X
ABCC1 p.Tyr440Phe 18775981:213:24
status: NEW
Login to comment

215 The Y440F mutation has a major deleterious effect on the transport of LTC4 and the S-methyl GSH-stimulated transport of E13SO4 (Fig. 3, B and D) but not on the other estrogen conjugate tested (E217betaG) or MTX (Fig. 3, C and E).
X
ABCC1 p.Tyr440Phe 18775981:215:4
status: NEW
Login to comment

216 Because we have shown that the Y440F mutant protein has reduced affinity for LTC4 compared with wild-type MRP1 (Fig. 4B), it is possible that the Y440F mutation also affects the affinity for E13SO4 and/or S-methyl GSH.
X
ABCC1 p.Tyr440Phe 18775981:216:31
status: NEW
X
ABCC1 p.Tyr440Phe 18775981:216:146
status: NEW
Login to comment

217 To test the former hypothesis, we attempted to determine a Km for the transport of E13SO4 by wild-type MRP1 and the Y440F mutant.
X
ABCC1 p.Tyr440Phe 18775981:217:116
status: NEW
Login to comment

222 Shown are wild-type MRP1 (f), Y440F (Œ), I441L (), and Y440F/I441L (ࡗ).
X
ABCC1 p.Tyr440Phe 18775981:222:30
status: NEW
X
ABCC1 p.Tyr440Phe 18775981:222:67
status: NEW
Login to comment

226 [3 H]LTC4 photolabeling of membrane vesicle isolated from Sf21 cells expressing wild-type and mutant MRP1 proteins. A, immunoblot showing the relative amounts of MRP1 protein in each sample after adjustment for relative MRP1 protein expression; wild-type MRP1 (35 ␮g) and mutants Y440F (75 ␮g), I441L (22 ␮g), and Y440F/I441L (20 ␮g).
X
ABCC1 p.Tyr440Phe 18775981:226:287
status: NEW
X
ABCC1 p.Tyr440Phe 18775981:226:335
status: NEW
Login to comment

233 To test whether the Y440F mutation alters the binding characteristics of S-methyl GSH and thus E13SO4 transport, we examined the binding of a GSH analog, azidophenacyl-GSH, to wild-type and mutant MRP1 expressed in stably transfected HEK cells.
X
ABCC1 p.Tyr440Phe 18775981:233:20
status: NEW
Login to comment

239 In contrast, the Y440F mutation, which reduced S-methyl GSH-stimulated transport of E13SO4 by approximately 65% (Fig. 3D), markedly decreased photolabeling with azidophenacyl-[35 S]GSH (Fig. 7C).
X
ABCC1 p.Tyr440Phe 18775981:239:17
status: NEW
Login to comment

240 This suggests that the affinity for this GSH derivative is dramatically affected by the Y440F mutation, as was found for LTC4.
X
ABCC1 p.Tyr440Phe 18775981:240:88
status: NEW
Login to comment

241 The reduced affinity for both azidophenacyl GSH and LTC4 suggests that the Y440F mutation may alter the interaction of MRP1 with the GSH moiety of both compounds and thus may decrease E13SO4 transport by reducing the affinity for GSH and S-methyl GSH.
X
ABCC1 p.Tyr440Phe 18775981:241:75
status: NEW
Login to comment

242 Effect of the Y440F, I441L, M443L, and Y440F/I441L Mutations on Resistance to Vincristine, Doxorubicin, and VP-16.
X
ABCC1 p.Tyr440Phe 18775981:242:14
status: NEW
X
ABCC1 p.Tyr440Phe 18775981:242:39
status: NEW
Login to comment

243 Lastly, the drug-resistance profiles of Y440F, I441L, M443L, and Y440F/I441L mutant proteins were examined because unlike MRP1, the profile of resistance to natural product drugs conferred by MRP3 is restricted primarily to epipodophyllotoxins (Deeley et al., 2006).
X
ABCC1 p.Tyr440Phe 18775981:243:40
status: NEW
X
ABCC1 p.Tyr440Phe 18775981:243:65
status: NEW
Login to comment

260 The three single mutations each decreased resistance to vincristine and VP-16, 2-to 3-fold, whereas only the Y440F mutation resulted in a major decrease in resistance to doxorubicin.
X
ABCC1 p.Tyr440Phe 18775981:260:109
status: NEW
Login to comment

261 The effect of the double Y440F/I441I mutation seemed to be additive with respect to both VP-16 and doxorubicin resistance but resulted in no greater decrease in resistance to vincristine than either mutation alone.
X
ABCC1 p.Tyr440Phe 18775981:261:25
status: NEW
Login to comment

280 It is noteworthy that conservative substitution of Tyr440 with Phe as present in MRP3 reduced LTC4 transport by ϳ60% with little effect on transport of E217betaG.
X
ABCC1 p.Tyr440Phe 18775981:280:51
status: NEW
Login to comment

282 The Y440F mutation resulted in a significant decrease in the apparent affinity for LTC4 (4-5-fold increase in Km), whereas Vmax was not affected.
X
ABCC1 p.Tyr440Phe 18775981:282:4
status: NEW
Login to comment

283 In addition, photolabeling of the Y440F protein by [3 H]LTC4 was markedly decreased.
X
ABCC1 p.Tyr440Phe 18775981:283:34
status: NEW
Login to comment

284 Taken together, the data strongly suggested that the primary defect in the Y440F protein was at the level of LTC4 binding.
X
ABCC1 p.Tyr440Phe 18775981:284:75
status: NEW
Login to comment

292 In particular, the relatively conservative substitution with Trp not only decreased LTC4 transport by ϳ75%, but unlike the Y440F mutation, also essentially eliminated transport of E217betaG.
X
ABCC1 p.Tyr440Phe 18775981:292:129
status: NEW
Login to comment

295 In contrast to the Y440F mutation, the conservatively substituted I441L mutation had no effect on LTC4 or MTX transport but decreased transport of both E217betaG and E13SO4, whereas the M443L mutation decreased transport of all three conjugated substrates but not TABLE 2 Relative Drug Resistance of HEK293 Cells Transfected with Wild-Type and Mutant MRP1 Transfectant Drug (Relative Resistance Factora ) Vincristine VP-16 Doxorubicin HEKMRP1 15.6 Ϯ 2.5 16.2 Ϯ 4.9 4.5 Ϯ 0.3 HEKMRP1-Y440F 2.4 Ϯ 0.5 (5.1) 2.7 Ϯ 0.8 (6.0) 1.3 Ϯ 0.2 (1.9) HEKMRP1-1441L 8.9 Ϯ 2.5 (9.7) 4.1 Ϯ 1.2 (4.4) 3.7 Ϯ 1.4 (4.1) HEKMRP1-M443L 6.5 Ϯ 1.2 (6.0) 5.8 Ϯ 0.5 (5.4) 3.8 Ϯ 0.7 (3.6) HEKMRP1-Y440F/1441L 3.9 Ϯ 1.0 (7.5) 1.3 Ϯ 0.3 (1.7) 1.2 Ϯ 0.2 (1.5) HEKMRP3 1.1 Ϯ 0.1 6.4 Ϯ 1.9 0.87 Ϯ 0.2 a The relative resistance factor was obtained by dividing the IC50 values for the wild-type or mutant MRP1-transfected cells by the IC50 value for cells transfected with the expression vector alone.
X
ABCC1 p.Tyr440Phe 18775981:295:19
status: NEW
X
ABCC1 p.Tyr440Phe 18775981:295:501
status: NEW
X
ABCC1 p.Tyr440Phe 18775981:295:741
status: NEW
Login to comment

303 Most significantly, the conservative substitution of Lys332 by Arg increased the Km for LTC4 ϳ5-fold without affecting the Vmax, as is the case with the Y440F mutation.
X
ABCC1 p.Tyr440Phe 18775981:303:159
status: NEW
Login to comment

307 The Y440F mutation had little effect on either E217betaG or MTX transport but markedly decreased S-methyl GSH-stimulated E13SO4 transport, and photolabeling with the GSH analog azidophenacyl- [35 S]GSH was severely reduced.
X
ABCC1 p.Tyr440Phe 18775981:307:4
status: NEW
Login to comment

309 However, it is clear that the Y440F mutation almost entirely eliminates binding of azidophenacyl-GSH, as well as LTC4.
X
ABCC1 p.Tyr440Phe 18775981:309:30
status: NEW
Login to comment

311 Consistent with this suggestion, the Y440F mutation resulted in a major decrease in resistance to all three classes of drugs, transport of, or resistance to which, has been shown to be GSH-dependent (Loe et al., 1996b, 1998; Rappa et al., 1997; Renes et al., 1999).
X
ABCC1 p.Tyr440Phe 18775981:311:37
status: NEW
Login to comment

PMID: 21143116 [PubMed] He SM et al: "Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1)."
No. Sentence Comment
792 The Tyr440Phe mutant expressed in Sf21 cells showed a 5-fold higher Km for LTC4 and substantially reduced photolabeling of MRP1/ABCC1 by both [3 H]LTC4 and the GSH derivative, azidophenacyl-[35 S]GSH [374].
X
ABCC1 p.Tyr440Phe 21143116:792:4
status: NEW
Login to comment

794 In addition, the Tyr440Phe, Ile441Leu, Met443Leu mutations decreased resistance to vincristine and etoposide 2-to 3-fold, whereas only the Tyr440Phe mutant displayed a major decrease in resistance to doxorubicin [374].
X
ABCC1 p.Tyr440Phe 21143116:794:17
status: NEW
X
ABCC1 p.Tyr440Phe 21143116:794:139
status: NEW
Login to comment